Pear Bio vs Tango Therapeutics
Pear Bio
Patient-centered cancer precision medicine
8 employees · est. 2017 · London, United Kingdom
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines
182 employees · est. 2017 · Boston, United States
Tango Therapeutics is the larger of the two.
4 signals in the last 90 days
Side-by-Side Comparison
| Metric | Pear Bio | Tango Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2017 |
| Headquarters | ||
| Headquarters | London, United Kingdom | Boston, United States |
| Employees | ||
| Employees | 8 | 182 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $19.79M | $351.00M |
| Funding Rounds | ||
| Funding Rounds | 9 | 4 |
| Services | ||
| Services | Personalized Testing Services, Drug Discovery | Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Biopharmaceutical Companies, Medical Researchers | Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors |
| Taxonomy | ||
| Taxonomy | Precision MedicineCancer BiologyFunctional Genomics3D Microtumor PlatformsComputational BiologyDrug Discovery +9 | Clinical-stagePrecision MedicineCancer TreatmentTumor Suppressor TargetingSynthetic LethalityCRISPR-based Discovery +8 |
| Website | ||
| Website | pearbio.com | tangotx.com |
About Pear Bio
Pear Bio, founded in 2017 and headquartered in the United Kingdom, is making strides in the fields of Biotechnology and Health Care with its focus on Patient-centered cancer precision medicine. The company employs a proprietary computational biology platform to unravel intricate cancer biology, faci...
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next genera...
Also comparing in this category
Comparing more than these two?
Get Pear Bio, Tango Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Pear Bio compare?
A PDF of Pear Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Pear Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Pear Bio on 15 Jun 2026, and Tango Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
